• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘油醛衍生的吡啶鎓通过 RAGE 相互作用引起肾小管细胞损伤。

Glyceraldehyde-Derived Pyridinium Evokes Renal Tubular Cell Damage via RAGE Interaction.

机构信息

Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume 830-0011, Japan.

Department of Chemistry, Kurume University School of Medicine, Kurume 830-0011, Japan.

出版信息

Int J Mol Sci. 2020 Apr 9;21(7):2604. doi: 10.3390/ijms21072604.

DOI:10.3390/ijms21072604
PMID:32283652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7177832/
Abstract

Glyceraldehyde-derived advanced glycation end products (glycer-AGEs) contribute to proximal tubulopathy in diabetes. However, what glycer-AGE structure could evoke tubular cell damage remains unknown. We first examined if deleterious effects of glycer-AGEs on reactive oxygen species (ROS) generation in proximal tubular cells were blocked by DNA-aptamer that could bind to glyceraldehyde-derived pyridinium (GLAP) (GLAP-aptamer), and then investigated whether and how GLAP caused proximal tubular cell injury. GLAP-aptamer and AGE-aptamer raised against glycer-AGEs were prepared using a systemic evolution of ligands by exponential enrichment. The binding affinity of GLAP-aptamer to glycer-AGEs was measured with a bio-layer interferometry. ROS generation was evaluated using fluorescent probes. Gene expression was analyzed by reverse transcription-polymerase chain reaction (RT-PCR). GLAP-aptamer bound to glycer-AGEs with a dissociation constant of 7.7 × 10 M. GLAP-aptamer, glycer-AGE-aptamer, or antibodies directed against receptor for glycer-AGEs (RAGE) completely prevented glycer-AGE- or GLAP-induced increase in ROS generation, MCP-1, PAI-1, or RAGE gene expression in tubular cells. Our present results suggest that GLAP is one of the structurally distinct glycer-AGEs, which may mediate oxidative stress and inflammatory reactions in glycer-AGE-exposed tubular cells. Blockade of the interaction of GLAP-RAGE by GLAP-aptamer may be a therapeutic target for proximal tubulopathy in diabetic nephropathy.

摘要

甘油醛衍生的晚期糖基化终产物(甘油-AGEs)导致糖尿病近端肾小管病变。然而,甘油-AGE 的结构如何引起肾小管细胞损伤尚不清楚。我们首先研究了针对甘油醛衍生的吡啶(GLAP)的 DNA 适体(GLAP-适体)是否可以阻断甘油-AGE 对近端肾小管细胞中活性氧(ROS)生成的有害影响,然后研究了 GLAP 是否以及如何引起近端肾小管细胞损伤。使用指数富集的配体系统进化制备了针对甘油-AGE 的 GLAP-适体和 AGE-适体。使用生物层干涉测量法测量 GLAP-适体与甘油-AGEs 的结合亲和力。使用荧光探针评估 ROS 的生成。通过逆转录-聚合酶链反应(RT-PCR)分析基因表达。GLAP-适体与甘油-AGE 的解离常数为 7.7×10 M。GLAP-适体、甘油-AGE-适体或针对甘油-AGE 受体(RAGE)的抗体完全阻止了甘油-AGE 或 GLAP 诱导的 ROS 生成、MCP-1、PAI-1 或 RAGE 基因表达的增加在肾小管细胞中。我们目前的结果表明,GLAP 是结构上不同的甘油-AGE 之一,它可能介导暴露于甘油-AGE 的肾小管细胞中的氧化应激和炎症反应。GLAP-aptamer 阻断 GLAP-RAGE 的相互作用可能是糖尿病肾病中近端肾小管病变的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fc8/7177832/e0143ca4e3d6/ijms-21-02604-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fc8/7177832/6722a7e645d2/ijms-21-02604-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fc8/7177832/e0143ca4e3d6/ijms-21-02604-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fc8/7177832/6722a7e645d2/ijms-21-02604-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fc8/7177832/e0143ca4e3d6/ijms-21-02604-g002.jpg

相似文献

1
Glyceraldehyde-Derived Pyridinium Evokes Renal Tubular Cell Damage via RAGE Interaction.甘油醛衍生的吡啶鎓通过 RAGE 相互作用引起肾小管细胞损伤。
Int J Mol Sci. 2020 Apr 9;21(7):2604. doi: 10.3390/ijms21072604.
2
Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE.甘油醛衍生的吡啶鎓(GLAP)通过与晚期糖基化终末产物受体(RAGE)相互作用,在内皮细胞中引发氧化应激、炎症和血栓形成反应。
Cardiovasc Diabetol. 2015 Jan 8;14:1. doi: 10.1186/s12933-014-0162-3.
3
DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice.针对晚期糖基化终产物受体的 DNA 适体可抑制糖尿病小鼠肾小管损伤并改善胰岛素抵抗。
Diab Vasc Dis Res. 2021 Jan-Feb;18(1):1479164121990533. doi: 10.1177/1479164121990533.
4
Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis.色素上皮衍生因子(PEDF)通过抑制晚期糖基化终产物(AGEs)-受体(RAGE)轴抑制早期糖尿病肾病近端肾小管细胞损伤。
Pharmacol Res. 2011 Mar;63(3):241-8. doi: 10.1016/j.phrs.2010.11.008. Epub 2010 Nov 27.
5
Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.普伐他汀通过降低晚期糖基化终产物受体(RAGE)水平抑制晚期糖基化终产物(AGEs)诱导的近端肾小管细胞凋亡和损伤。
Metabolism. 2012 Aug;61(8):1067-72. doi: 10.1016/j.metabol.2012.01.006. Epub 2012 Mar 3.
6
Advanced glycation end products evoke inflammatory reactions in proximal tubular cells via autocrine production of dipeptidyl peptidase-4.晚期糖基化终产物通过自分泌产生二肽基肽酶-4引起近端肾小管细胞的炎症反应。
Microvasc Res. 2018 Nov;120:90-93. doi: 10.1016/j.mvr.2018.07.004. Epub 2018 Jul 26.
7
Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis.钠-葡萄糖共转运蛋白 2 介导的氧化应激增强了晚期糖基化终产物诱导的肾小管细胞凋亡。
Diabetes Metab Res Rev. 2013 Jul;29(5):406-12. doi: 10.1002/dmrr.2407.
8
Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.二甲双胍通过降低晚期糖基化终产物受体(RAGE)的表达来减少活性氧的生成,从而抑制晚期糖基化终产物(AGEs)诱导的肾小管细胞损伤。
Horm Metab Res. 2012 Nov;44(12):891-5. doi: 10.1055/s-0032-1321878. Epub 2012 Aug 3.
9
Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation.硝苯地平通过激活过氧化物酶体增殖物激活受体-γ抑制晚期糖基化终产物(AGEs)及其受体(RAGE)相互作用介导的近端肾小管细胞损伤。
Biochem Biophys Res Commun. 2010 Jul 23;398(2):326-30. doi: 10.1016/j.bbrc.2010.06.093. Epub 2010 Jun 26.
10
Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression.厄贝沙坦通过抑制晚期糖基化终末产物(AGE)受体(RAGE)的表达,抑制体外 AGE 诱导的近端肾小管细胞损伤。
Pharmacol Res. 2010 Jan;61(1):34-9. doi: 10.1016/j.phrs.2009.07.004. Epub 2009 Jul 25.

引用本文的文献

1
Correlation between circulating advanced glycation end products and thioredoxin-interacting protein levels and renal fat content in type 2 diabetes mellitus patients.2型糖尿病患者循环晚期糖基化终产物与硫氧还蛋白相互作用蛋白水平及肾脂肪含量之间的相关性
Diabetol Metab Syndr. 2024 Jun 30;16(1):144. doi: 10.1186/s13098-024-01361-5.
2
New insights into the role of empagliflozin on diabetic renal tubular lipid accumulation.恩格列净对糖尿病肾小管脂质蓄积作用的新见解。
Diabetol Metab Syndr. 2022 Aug 23;14(1):121. doi: 10.1186/s13098-022-00886-x.
3
Immunopathology of Atherosclerosis and Related Diseases: Focus on Molecular Biology.

本文引用的文献

1
Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition.恩格列净可降低高糖诱导的氧化应激和 miR-21 依赖的 TRAF3IP2 诱导及 REck 抑制,从而抑制人肾近端肾小管上皮细胞迁移和上皮间质转化。
Cell Signal. 2020 Apr;68:109506. doi: 10.1016/j.cellsig.2019.109506. Epub 2019 Dec 17.
2
Renoprotection of dapagliflozin in human renal proximal tubular cells via the inhibition of the high mobility group box 1‑receptor for advanced glycation end products‑nuclear factor‑κB signaling pathway.达格列净通过抑制晚期糖基化终产物高迁移率族蛋白 1 受体-核因子-κB 信号通路对人近端肾小管细胞的肾保护作用。
Mol Med Rep. 2018 Oct;18(4):3625-3630. doi: 10.3892/mmr.2018.9393. Epub 2018 Aug 17.
3
动脉粥样硬化及相关疾病的免疫病理学:聚焦于分子生物学。
Int J Mol Sci. 2021 Apr 15;22(8):4080. doi: 10.3390/ijms22084080.
4
Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD.晚期糖基化终末产物(AGE)与AGE受体的可溶性形式:在慢性肾脏病中作为死亡风险因素的新作用。
Biomedicines. 2020 Dec 21;8(12):638. doi: 10.3390/biomedicines8120638.
Contribution of myo-inositol oxygenase in AGE:RAGE-mediated renal tubulointerstitial injury in the context of diabetic nephropathy.肌醇加氧酶在糖尿病肾病 AGE:RAGE 介导的肾间质小管损伤中的作用。
Am J Physiol Renal Physiol. 2018 Jan 1;314(1):F107-F121. doi: 10.1152/ajprenal.00434.2017. Epub 2017 Sep 20.
4
Methylglyoxal-derived hydroimidazolone-1 evokes inflammatory reactions in endothelial cells via an interaction with receptor for advanced glycation end products.甲基乙二醛衍生的氢咪唑啉酮-1通过与晚期糖基化终产物受体相互作用在内皮细胞中引发炎症反应。
Diab Vasc Dis Res. 2017 Sep;14(5):450-453. doi: 10.1177/1479164117715855. Epub 2017 Jun 20.
5
Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease.近端肾小管病:糖尿病肾病的主要推动者和关键治疗靶点
Diabetes. 2017 Apr;66(4):791-800. doi: 10.2337/db16-0796.
6
Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory.糖尿病中的糖基化与心血管疾病:代谢记忆概念的视角
J Diabetes. 2017 Feb;9(2):141-148. doi: 10.1111/1753-0407.12475. Epub 2016 Sep 25.
7
Tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, suppresses renal damage in KKAy/Ta mice, obese and type 2 diabetic animals.托格列净是一种钠-葡萄糖协同转运蛋白2的选择性抑制剂,可抑制KKAy/Ta小鼠(肥胖型2型糖尿病动物)的肾脏损伤。
Diab Vasc Dis Res. 2016 Nov;13(6):438-441. doi: 10.1177/1479164116657304. Epub 2016 Jul 12.
8
Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.晚期糖基化终末产物:糖尿病血管并发症的分子靶点
Mol Med. 2015 Oct 27;21 Suppl 1(Suppl 1):S32-40. doi: 10.2119/molmed.2015.00067.
9
Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress.Kallistatin 通过抑制 AGE-RAGE 诱导的氧化应激来保护 db/db 小鼠免受糖尿病肾病的侵害。
Kidney Int. 2016 Feb;89(2):386-98. doi: 10.1038/ki.2015.331.
10
Tofogliflozin, A Highly Selective Inhibitor of SGLT2 Blocks Proinflammatory and Proapoptotic Effects of Glucose Overload on Proximal Tubular Cells Partly by Suppressing Oxidative Stress Generation.托格列净,一种高选择性的钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂,部分通过抑制氧化应激的产生,阻断葡萄糖过载对近端肾小管细胞的促炎和促凋亡作用。
Horm Metab Res. 2016 Mar;48(3):191-5. doi: 10.1055/s-0035-1555791. Epub 2015 Jul 9.